$27.5 0.0 0.0%
Last Trade - 08/11/18
| Market Cap | £n/a |
| Enterprise Value | £n/a |
| Revenue | £202.9m |
| Position in Universe | th / 6850 |
| Industry | Market | |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
| Year End 31st Dec | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018E | 2019E | CAGR / Avg | |
|---|---|---|---|---|---|---|---|---|---|---|
| 135.1 | 157.6 | 186.7 | 216 | 236.6 | 258 | 289.6 | 317.7 | +13.8% | ||
|
x
|
||||||||||
| Profitability | ||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
| Cashflow | ||||||||||
| Dividends | ||||||||||
| Balance Sheet | ||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing % | |||
| Net Gearing % | |||
| Cash / Assets % |
| Liquidity (ttm) | ||
|---|---|---|
| Curr. Ratio | ||
| Quick Ratio | ||
| Interest Cov. | ||
| Efficiency (ttm) | ||
|---|---|---|
| Asset Turnover | ||
| Recs Turnover | ||
| Stock Turnover | ||
| Latest interim period vs. prior period | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
| 3yr Compound Annual Growth Rate | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
Revenue
Net Income
Normalised EPS
PE Ratio Range
Dividend Yield Range
|
Price Target:
( below Price)
|
31st Dec 2021
|
31st Dec 2022
|
||||
|---|---|---|---|---|---|---|
| Est. Long Term Growth Rate: |
Net Profit () |
EPS () |
DPS () |
Net Profit () |
EPS () |
DPS () |
| Consensus Estimate | ||||||
| 1m Change | ||||||
| 3m Change | ||||||
K2M Group Holdings, Inc. is a medical device company focused on designing, developing and commercializing spine and minimally invasive technologies and techniques. The Company's solutions are focused on achieving three-dimensional Total Body Balance. Its spine products are used by spine surgeons to treat spinal pathologies, such as deformity (primarily scoliosis), trauma and tumor. Its products consist of implants, disposables and instruments, which are marketed and sold primarily to hospitals for use by spine surgeons. As of December 31, 2016, its product portfolio consisted of 83 product lines that are used in complex spine, minimally invasive surgery (MIS) and degenerative surgeries. Its technologies include EVEREST, MESA, Rail 4D, Quicket Deformity, CASCADIA, CAPRI, SERENGETI, RAVINE and tifix. Its degenerative spine technologies are used to treat degenerative spine disorders and include products, such as cervical, thoracic and lumbar spinal fusion devices and interbody devices.
| Last Annual | December 31st, 2017 |
| Last Interim | September 30th, 2018 |
| Incorporated | June 29, 2010 |
| Public Since | May 8, 2014 |
| No. of Shareholders: | 30 |
| No. of Employees: | 484 |
| Sector | Healthcare |
| Industry | Healthcare Equipment & Supplies |
| Index | |
| Exchange | NASDAQ Global Select Market |
| Shares in Issue | 43,737,010 |
| Free Float | (0.0%) |
| Eligible for |
✓
ISAs
✓
SIPPs
|
| Address | 600 Hope Pkwy SE, LEESBURG, 20175-4428, United States |
| Web | http://www.k2m.com |
| Phone | +1 703 7773155 |
| Contact | () |
| Auditors | Ernst & Young LLP |
As of 08/11/18, shares in K2M Group Inc are trading at $27.5, giving the company a market capitalisation of £n/a. This share price information is delayed by 15 minutes.
Shares in K2M Group Inc are currently trading at $27.5 and the price has moved by 48.81% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the K2M Group Inc price has moved by 2.57% over the past year.
Of the analysts with advisory recommendations for K2M Group Inc, there are there are currently 0 "buy" , 7 "hold" and 0 "sell" recommendations. The overall consensus recommendation for K2M Group Inc is Hold. You can view the full broker recommendation list by unlocking its StockReport.
K2M Group Inc is scheduled to issue upcoming financial results on the following dates:
K2M Group Inc does not currently pay a dividend.
K2M Group Inc does not currently pay a dividend.
K2M Group Inc does not currently pay a dividend.
To buy shares in K2M Group Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
Shares in K2M Group Inc are currently trading at $27.5, giving the company a market capitalisation of £n/a.
Here are the trading details for K2M Group Inc:
We were not able to load our ranking data for K2M Group Inc
We were not able to load any forecast data for K2M Group Inc.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like K2M Group Inc. Over the past six months, the relative strength of its shares against the market has been 8.17%. At the current price of $27.5, shares in K2M Group Inc are trading at % against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
We were not able to find PE ratio data for K2M Group Inc.
We were unable to find the directors for K2M Group Inc.
Here are the top five shareholders of K2M Group Inc based on the size of their shareholding:
